loading...| Preferred Name |
Betrixaban |
|
| Synonyms |
Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy- N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- Methoxybenzamide BETRIXABAN Betrixaban Bevyxxa PRT-054021 |
|
| Definitions |
An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Betrixaban is primarily excreted unchanged in the bile and has a half life of about 19 hours. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75154 |
|
| Accepted_Therapeutic_Use_For |
prophylaxis of venous thromboembolism (VTE) |
|
| CAS_Registry |
330942-05-7 |
|
| Chemical_Formula |
C23H22ClN5O3 |
|
| code |
C75154 |
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600 |
|
| Contributing_Source |
CTRP FDA HemOnc |
|
| DEFINITION |
An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Betrixaban is primarily excreted unchanged in the bile and has a half life of about 19 hours. |
|
| Display_Name |
Betrixaban |
|
| FDA_UNII_Code |
74RWP7W0J9 |
|
| FULL_SYN |
Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy- N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- Methoxybenzamide BETRIXABAN Betrixaban Bevyxxa PRT-054021 |
|
| label |
Betrixaban |
|
| Legacy Concept Name |
Betrixaban |
|
| Preferred_Name |
Betrixaban |
|
| prefixIRI |
Thesaurus:C75154 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C2698385 |
|
| subClassOf |